Fulcrum Therapeutics
NasdaqGM:FULC
$ 6,98
+ $0,28 (4,18%)
6,98 $
+$0,28 (4,18%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,12
Earnings Per Share
$1,48
Revenue Per Share
20,77%
Gross Margin %
$0,45 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,12
Revenue Per Share
$1,48
Gross Margin %
20,77%
Market Cap
$0,45 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $-1,18 $-0,12 $-1,59 $-2,43 $-2,29 $-2,79 $-8,13 $-3,01
Earnings Earnings $-78,59M $-6,48M $-98,48M $-150,08M $-93,04M $-90,81M $-184,39M $-5,18M
RPS Revenue Per Share $0,00 $0,00 $1,48 $0,05 $0,10 $0,47 $0,27 $0,00 $0,00
Revenue Revenue $0,00M $0,00M $80,00M $2,81M $6,34M $19,16M $8,82M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-56,51M $-100,60M $-90,97M $-97,05M $-78,48M $-53,66M $-39,48M $0,00M
FCF Free Cash Flow $0,00M $-63,98M $-2,50M $-98,54M $-99,01M $-80,19M $-55,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% -24,79% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 20,77% 100,00% 0,00% -263,73% 100,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-0,95 $-0,04 $-1,49 $-2,20 $-2,27 $-2,17 $-3,66 $-25,09
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 66,6M 66,6M 53,98M 61,94M 61,76M 40,63M 32,55M 22,68M 1,72M
×